|
Lonnie Moulder has served as President and CEO of MGI PHARMA since 2003. He joined MGI PHARMA in 1999 as Executive Vice President and assumed the role of President and Chief Operating Officer in May 2002. Prior to joining MGI PHARMA, he was part of the founding management team and Vice President, Business Development and Commercial Affairs, of Eligix, Inc., a venture-stage biomedical company that was based in Boston, MA. This followed 16 years of various commercial roles with Hoechst Marion Roussel (now Sanofi Aventis) and its predecessor companies, Marion Laboratories and Marion Merrell Dow. Mr. Moulder’s tenure at HMR culminated as Product Group Director, Oncology and Anti-Infective Products. He currently serves as a board of director for Methylgene, Inc. and LifeScience Alley. Mr. Moulder received a B.S. in pharmacy from Temple University in 1980 and began his career as a clinical pharmacist. He also holds a M.B.A. from the University of Chicago. | 